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Summary 
 
We report the clinical and molecular findings in a patient with a mild form of 
recessive dystrophic epidermolysis bullosa (RDEB) and aortic insufficiency. To our 
knowledge, this is the first report of association between RDEB and abnormalities of the 
aortic valve. Analysis of the COL7A1 gene has revealed two new mutations, a 20-bp 
duplication and a splice-site mutation. These findings support the recessive inheritance of 
the moderately severe cases of mild RDEB. 
 
 3 
Report 
 
Dystrophic epidermolysis bullosa (DEB) results from mutations in the COL7A1 gene on 
chromosome 3p, which encodes type VII collagen, the major component of anchoring 
fibrils. The site and specific nature of the underlying mutations determine the clinical 
phenotype, which ranges widely from a relatively mild disorder, typically inherited 
autosomal dominantly (DDEB), to a severe, mutilating condition, inherited autosomal 
recessively (RDEB). Over 100 distinct mutations within the two non-collagenous 
domains, NC1, NC2, and the helical domain of COL7A1 have been identified in DEB 
patients,1 and in the majority of cases, the mutations have been specific to individual 
families, with only a few reported cases of recurrent mutations.1 2 3 The correlation 
between the mutations and the observed clinical phenotypes is still emerging. 
Probands with dominant DEB, characteristically have a glycine substitution 
mutation on one allele, while patients with the most severe type of RDEB have premature 
termination codon (PTC) mutations in both alleles of COL7A1 resulting in a complete 
lack of anchoring fibrils and collagen VII. 
Within the dominant and recessive forms of DEB, there is another sub-group of 
patients in which the affected individuals have a relatively mild phenotype, the parents 
appear unaffected, and the family history is negative for blistering disease.  These so 
called “sporadic” cases of DEB were previously thought to have a new dominant DEB 
mutation, however, many patients in this group are now known to have a mild, recessive 
form of DEB.4 
In the mild forms of RDEB, at least one of the COL7A1 alleles typically contains 
a missense mutation, which renders it capable of producing full-length, albeit 
functionally imperfect, type VII collagen polypeptides.5 The other allele can contain a 
PTC, a second missense mutation, an in-frame deletion or a splice site mutation. As a 
result of this combination of mutations, mutant full-length type VII collagen molecules 
may be able to assemble into a small number of poorly functioning anchoring fibrils. The 
resulting attachment structures, though weak, are present, which accounts for the milder 
phenotype observed in these forms of RDEB. 
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RDEB has been associated with several long-term sequelae. Some of the most 
common complications include nutritional deprivation secondary to severe mucous 
membrane lesions leading to esophageal strictures and scarring.  Dental caries are also 
frequently observed. Chronic anemia due to increased blood loss from the skin and 
gastrointestinal tract, coupled with decreased oral intake often results in continuous iron 
therapy supplemented by blood transfusions. Cutaneous carcinomas, particularly 
squamous cell carcinoma, have also been associated with RDEB. 
Although far less commonly observed, certain cardiac conditions have been 
reported in patients with RDEB. Several cases of dilated cardiomyopathy in children with 
RDEB have been described.6 7 8 In addition, mitral valve prolapse, which has a known 
association with several connective tissue disorders, has also been reported in two 
patients with RDEB. 9 10 The common pathological mechanism between the valvular 
anomaly and RDEB is thought to be due to an abnormality of collagen metabolism. 10 
Herein, we report two new COL7A1 mutations, a 20-bp duplication, and a splice-
site mutation in a proband with clinically significant aortic insufficiency necessitating 
aortic valve replacement. To our knowledge, this is the first time that abnormalities of the 
aortic valve have been reported in a patient with RDEB. In addition, these findings 
extend the body of evidence implicating inheritance of two mutations of intermediate 
severity in the mild form of RDEB. 
The proband reported here is a 25-year-old male who is one of three siblings born 
to non-consanguineous, clinically unaffected parents.  There was no history of 
dermatological disease in the family.  Clinical findings in the patient included erosions 
and atrophic scarring in sites of previous trauma, such as bilateral knees, shins and heels.  
Complete nail dystrophy was noted, as was pseudosyndactyly of both hands (Fig. 1).  In 
addition, the patient had a history of chronic, progressive aortic regurgitation secondary 
to aortic valvular degeneration, with a severely dilated left ventricle, for which he 
underwent aortic valve replacement surgery in the spring of 2001.  The histological 
findings showed dysplasia of the aortic valve, with focally abnormal architecture with 
accumulation of myxoid material and focal interruption of the fibrosa.  One portion of the 
tissue appeared to be an elastic artery with extensive fibrosis and loss of elastic tissue. 
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Previous studies have suggested that an underlying etiology for aortic valvular 
degeneration may be defective synthesis of collagen or elastic fibers, lending support to a 
possible link with EB. 11  Furthermore, in a recent case report, a Japanese EB patient with 
severe mitral regurgitation was shown to have similar microscopic myxomatous changes 
of the valve to that seen in our patient. These authors suggest that an abnormality in 
collagen metabolism may play a role in the development of valvular degeneration and EB. 
10  Further studies are necessary to determine whether a true relationship between these 
conditions exists, and if so, what common mechanisms and factors influence their 
development. 
In order to search for mutations in the COL7A1 gene, we used a combined 
strategy of heteroduplex analysis and direct PCR sequencing.  Genomic DNA was 
isolated from peripheral blood lymphocytes of the proband using PureGene DNA 
Isolation Kit (Gentra Systems, Minneapolis, MN) and used as a template for PCR 
amplification. 8µl of the PCR product was prepared for heteroduplex analysis using 
conformation sensitive gel electrophoresis (CSGE). Heteroduplexes were visualized by 
staining with ethidium bromide.  Bands of altered mobility detected in the CSGE gel 
were directly sequenced using the ABI Prism Big Dye Terminator Cycle Sequencing 
Ready Reaction Kit (PE Applied Biosystems, Foster City, CA). 
Sequencing of the PCR products corresponding to exons 23 and 64 from the 
patient's DNA resulted in the identification of two novel mutations in the COL7A1 gene, 
a 20 bp duplication at the intron 22/exon 23 boundary, and an A-to-G transition at 
position +4 of the 5’ donor splice site of intron 64 (IVS 64 +4 A>G) (Fig. 2).  To verify 
the duplication mutation, we subcloned the PCR product corresponding to exons 22-24 
using the TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA).  We sequenced a total of 7 
clones, corresponding to 2 wild type and 5 mutant alleles.  To verify the splice site 
mutation, we used a mismatched PCR strategy, with the following primers: 
5’TGGCCTGAATGGAA AAAACCTG3’ (forward) and 
5’CTATGTTTCTGGATGCATCTG3’ (reverse).  The forward primer introduces a Dde I 
restriction site in the wild-type allele. 
The screening of 72 control chromosomes from unrelated, healthy individuals 
failed to disclose the presence of the splice site mutation. The nature of the duplication 
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mutation, together with the absence of the splice variant in control subjects, suggests that 
these mutations are not common polymorphisms, but represent true pathogenetic 
mutations. 
Among several possibilities, the most likely explanation for the first mutant allele 
is a duplication of the sequence cctgcagAAGTGCCTGGGTC, at the intron 22/exon 23 
boundary within the amino-terminal non-collagenous NC-1 domain, specifically within 
the fibronectin type III-like repeat domain FN-9.  To our knowledge, this is the first time 
that this mutation has been reported. This duplication is predicted to lead to a PTC 59-bp 
downstream in exon 23 and could have several potential consequences: a frame-shift 
mutation with a PTC resulting in degradation of the mutant transcript by nonsense 
mediated mRNA decay, in-frame skipping of exon 23 or retention of intron 22. 
The majority of the COL7A1 PTC mutations that have been studied thus far at the 
mRNA level show marked COL7A1 mRNA decrease consistent with nonsense-mediated 
mRNA decay. 12  However, aberrant mRNA splicing around exon 23 is another possible 
consequence of the mutation found in this patient. In a previous study, a 16-bp 
intraexonic deletion in exon 87 of COL7A1 in a family with DDEB was identified, and 
predicted to generate a frameshift mutation and a downstream PTC. 13  Although the 
deletion did not disrupt any consensus splicing sequences, the mutation resulted in exon 
skipping and the subsequent restoration of the reading frame, instead of the expected 
generation of a PTC. 
The second mutation observed in our patient, an A-to-G transition, occurred at 
position +4 of the 5’ donor site of intron 64, within the central collagenous domain of the 
type VII collagen polypeptide. An A-to-G transition affecting the same position in the 5’ 
splice site has previously been reported in the beta-spectrin gene where it lead to skipping 
of an exon, a shift in the reading frame and a PTC within one amino acid residue of the 
novel sequence.14  More recently, an A-to G transition at position +4 within the 5’ splice 
site has been described in intron 87 of COL7A1 in a patient with the Hallopeau-Siemans 
variant of RDEB, where it also lead to a PTC.15  To our knowledge, this is the first 
incidence of this mutation in the COL7A1 gene. 
Because this mutation occurs within the 5’ donor splice site, its consequence is at 
the transcriptional level. To compare the splice sites from the wild-type and mutant 
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sequences, we calculated their consensus values according to Shapiro and Senapathy.16  In 
this procedure, splice sites are scored relative to the frequency with which the same bases 
have been found in 542 normal splice sites of primate genes. The splice-site score for the 
wild-type 5' donor splice site of intron 64 is 83.21% and for the mutated form of the 5' 
donor splice site of intron 64 is 72.45% (a sequence identical to the consensus gives a 
100% score). This could result in decreased efficiency of the splicing apparatus leading to 
lower levels of the expected mRNA transcript. This would explain the lack of phenotype 
in the parent from whom this mutant allele was inherited, as well as the relatively mild 
phenotype of the proband despite his recessive condition. 
On the other hand, the single base pair substitution could potentially result in an 
aberrant splicing pattern, leading to the complete skipping of exon 64, the retention of 
intron 64, or the activation of cryptic splice sites in the region. 
In conclusion, this case report exemplifies the notion that identification of disease 
causing mutations can be a valuable tool in the characterization of the functional domains 
of the encoded proteins, and may have important implications for understanding the 
complex genotype-to-phenotype correlations of EB and other heritable diseases. 
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Figure 1 Clinical presentation of the proband with mild RDEB.  Note the complete 
nail dystrophy of both hands (a) and feet (b), as well as pseudosyndactyly of the hands (c) 
seen in recessive DEB.  Healing erosions are also present (d). 
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Figure 2 Molecular findings in the COL7A1 gene (a) Pedigree of the proband with 
mild RDEB. The arrow denotes the proband. (b) Sequence of the 20-bp duplication 
mutation. Automated sequencing of the PCR product corresponding to exon 23 in a 
control subject (top), as well as the patient (bottom) are shown. Note the 20-bp 
duplication, indicated by arrows, in the affected individual heterozygous for this insertion 
in the mutant allele. (c) Sequence of the splice-site mutation.  Automated sequencing of 
the PCR product corresponding to IVS 64 in a control subject (top), as well as the patient 
(bottom) are shown.  Note the double peak indicated by an arrow in the affected 
individual heterozygous for the substitution (A-to-G) in the mutant allele. The 
corresponding peak in the wild-type sequence (A only) is also denoted by an arrow. 
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